UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 75

Sortiert nach

EMP2 is a novel therapeutic target for endometrial cancer stem cells

Oncogene, 2017-10, Vol.36 (42), p.5793-5807

2017

Link zum Volltext

Verfügbarkeit prüfen

EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF

Oncogene, 2013-11, Vol.32 (46), p.5369-5376

2013

Link zum Volltext

Verfügbarkeit prüfen

Aromatase inhibitors in human lung cancer therapy

Cancer research (Chicago, Ill.), 2005-12, Vol.65 (24), p.11287-11291

2005

Link zum Volltext

Verfügbarkeit prüfen

Expression of transcription factor Yin Yang 1 in prostate cancer

International journal of oncology, 2005-07, Vol.27 (1), p.131

2005

Link zum Volltext

Verfügbarkeit prüfen

Raf-1 Kinase Inhibitor Protein: Structure, Function, Regulation of Cell Signaling, and Pivotal Role in Apoptosis

Advances in Cancer Research, 2004, Vol.91, p.169-200

2004

Link zum Volltext

Verfügbarkeit prüfen

Identification of Genes Differentially Expressed in Rat Alveolar Type I Cells

American journal of respiratory cell and molecular biology, 2004-09, Vol.31 (3), p.309-316

2004

Link zum Volltext

Verfügbarkeit prüfen

Can we develop biomarkers that predict response of cancer patients to immunotherapy?

Biomarkers, 2005, Vol.10 (S1), p.69-76

2005

Link zum Volltext

Verfügbarkeit prüfen

Role of reactive oxygen metabolites in crocidolite asbestos toxicity to mouse macrophages

Cancer research (Chicago, Ill.), 1986-11, Vol.46 (11), p.5558-5566

1986

Link zum Volltext

Verfügbarkeit prüfen

COX‐2‐dependent stabilization of survivin in non‐small cell lung cancer

The FASEB journal, 2004-01, Vol.18 (1), p.206-208

2004

Link zum Volltext

Verfügbarkeit prüfen

Mapping the Ig superantigen-binding site of HIV-1 gp120

The Journal of immunology (1950), 1995-12, Vol.155 (11), p.5151

1995

Link zum Volltext

Verfügbarkeit prüfen

The tetraspan protein EMP2 modulates the surface expression of caveolins and glycosylphosphatidyl inositol-linked proteins

Molecular biology of the cell, 2004-05, Vol.15 (5), p.2073-2083

2004

Link zum Volltext

Verfügbarkeit prüfen

Revenge of the microbes : superantigens of the T and B cell lineage

The American journal of pathology, 1994-04, Vol.144 (4), p.623-636

1994

Link zum Volltext

Verfügbarkeit prüfen

Acute injury and regeneration of the mesothelium in response to asbestos fibers

The American journal of pathology, 1987-09, Vol.128 (3), p.426-445

1987

Link zum Volltext

Verfügbarkeit prüfen

Growth Factor Responses and Protooncogene Expression of Murine Mesothelial Cell Lines Derived from Asbestos-Induced Mesotheliomas

Toxicologic pathology, 1997-11, Vol.25 (6), p.565-573

1997

Link zum Volltext

Verfügbarkeit prüfen

Cytotoxicity of long and short crocidolite asbestos fibers in vitro and in vivo

Cancer research (Chicago, Ill.), 1990-08, Vol.50 (16), p.5153-5163

1990

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-03-12: Prognostic role of stem cell markers in triple-negative breast cancer (TNBC)

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P5-P5-03-12

2013

Link zum Volltext

Verfügbarkeit prüfen

31 EXPRESSION PATTERN OF EPITHELIAL MEMBRANE PROTEIN 2 IN NORMAL AND MALIGNANT SKIN AND LUNG

Journal of investigative medicine, 2004-01, Vol.52 (Suppl 1), p.S84-S84

2004

Link zum Volltext

Verfügbarkeit prüfen

Celecoxib Decreases Ki-67 Proliferative Index in Active Smokers

Clinical cancer research, 2006-01, Vol.12 (1), p.314-320

2006

Link zum Volltext

Verfügbarkeit prüfen

Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses

Biochemical and biophysical research communications, 2005-01, Vol.326 (1), p.218-227

2005

Link zum Volltext

Verfügbarkeit prüfen

Abstract P4-02-09: Extranuclear Estrogen Receptors in Human Breast Cancer

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P4-P4-02-09

2010

Link zum Volltext

Verfügbarkeit prüfen

Randomized, multicenter phase II study of erlotinib (E) or E plus fulvestrant (F) in previously treated advanced non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.TPS216-TPS216

2011

Link zum Volltext

Verfügbarkeit prüfen

Immunoglobulin VH3 gene products : natural ligands for HIV gp120

Science (American Association for the Advancement of Science), 1993-09, Vol.261 (5128), p.1588-1591

1993

Link zum Volltext

Verfügbarkeit prüfen

The tetraspan protein EMP2 increases surface expression of class I major histocompatibility complex proteins and susceptibility to CTL-mediated cell death

Clinical immunology (Orlando, Fla.), 2003-05, Vol.107 (2), p.129-136

2003

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase II study of erlotinib (E) alone or combined with fulvestrant (F) in previously treated patients with advanced non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.TPS295-TPS295

2010

Link zum Volltext

Verfügbarkeit prüfen

IL-20, an anti-angiogenic cytokine that inhibits COX-2 expression

Biochemical and biophysical research communications, 2005-07, Vol.333 (2), p.470-475

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(75)

Sprache

Englisch
(75)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EMP2 is a novel therapeutic target for endometrial cancer stem cells

EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF

Aromatase inhibitors in human lung cancer therapy

Expression of transcription factor Yin Yang 1 in prostate cancer

Raf-1 Kinase Inhibitor Protein: Structure, Function, Regulation of Cell Signaling, and Pivotal Role in Apoptosis

Identification of Genes Differentially Expressed in Rat Alveolar Type I Cells

Can we develop biomarkers that predict response of cancer patients to immunotherapy?

Role of reactive oxygen metabolites in crocidolite asbestos toxicity to mouse macrophages

COX‐2‐dependent stabilization of survivin in non‐small cell lung cancer

Mapping the Ig superantigen-binding site of HIV-1 gp120

The tetraspan protein EMP2 modulates the surface expression of caveolins and glycosylphosphatidyl inositol-linked proteins

Revenge of the microbes : superantigens of the T and B cell lineage

Acute injury and regeneration of the mesothelium in response to asbestos fibers

Growth Factor Responses and Protooncogene Expression of Murine Mesothelial Cell Lines Derived from Asbestos-Induced Mesotheliomas

Cytotoxicity of long and short crocidolite asbestos fibers in vitro and in vivo

Abstract P5-03-12: Prognostic role of stem cell markers in triple-negative breast cancer (TNBC)

31 EXPRESSION PATTERN OF EPITHELIAL MEMBRANE PROTEIN 2 IN NORMAL AND MALIGNANT SKIN AND LUNG

Celecoxib Decreases Ki-67 Proliferative Index in Active Smokers

Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses

Abstract P4-02-09: Extranuclear Estrogen Receptors in Human Breast Cancer

Randomized, multicenter phase II study of erlotinib (E) or E plus fulvestrant (F) in previously treated advanced non-small cell lung cancer (NSCLC)

Immunoglobulin VH3 gene products : natural ligands for HIV gp120

The tetraspan protein EMP2 increases surface expression of class I major histocompatibility complex proteins and susceptibility to CTL-mediated cell death

Randomized phase II study of erlotinib (E) alone or combined with fulvestrant (F) in previously treated patients with advanced non-small cell lung cancer (NSCLC)

IL-20, an anti-angiogenic cytokine that inhibits COX-2 expression

Suchergebnisse filtern